Akero Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Akero Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akero Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Akero Therapeutics by Goldman Sachs Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $18M | 783k | 23.46 |
2024-03-31 | $15M | 590k | 25.26 |
2023-12-31 | $14M | 613k | 23.35 |
2023-09-30 | $17M | 331k | 50.58 |
2023-06-30 | $9.8M | 209k | 46.69 |
2023-03-31 | $8.5M | 223k | 38.26 |
2022-12-31 | $10M | 186k | 54.80 |
2022-06-30 | $18M | 1.9M | 9.45 |
2022-03-31 | $16M | 1.1M | 14.19 |
2021-12-31 | $37M | 1.8M | 21.15 |
2021-09-30 | $697k | 31k | 22.36 |
2021-03-31 | $6.1M | 209k | 29.01 |
2020-12-31 | $6.7M | 260k | 25.80 |
2020-09-30 | $2.2M | 72k | 30.80 |
2020-06-30 | $1.8M | 71k | 24.93 |
2019-12-31 | $819k | 37k | 22.20 |
2019-09-30 | $594k | 26k | 22.74 |
2019-06-30 | $1.1M | 58k | 19.15 |